» Articles » PMID: 34049995

Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study

Overview
Specialty Neurology
Date 2021 May 29
PMID 34049995
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We sought to determine whether genetic risk modifies the effect of environmental risk factors for multiple sclerosis (MS). To test this hypothesis, we tested for statistical interaction between polygenic risk scores (PRS) capturing genetic susceptibility to MS and environmental risk factors for MS in UK Biobank.

Methods: People with MS were identified within UK Biobank using -coded MS or self-report. Associations between environmental risk factors and MS risk were quantified with a case-control design using multivariable logistic regression. PRS were derived using the clumping-and-thresholding approach with external weights from the largest genome-wide association study of MS. Separate scores were created including major histocompatibility complex (MHC) (PRS) and excluding (PRS) the MHC locus. The best-performing PRS were identified in 30% of the cohort and validated in the remaining 70%. Interaction between environmental and genetic risk factors was quantified using the attributable proportion due to interaction (AP) and multiplicative interaction.

Results: Data were available for 2,250 people with MS and 486,000 controls. Childhood obesity, earlier age at menarche, and smoking were associated with MS. The optimal PRS were strongly associated with MS in the validation cohort (PRS: Nagelkerke's pseudo-R 0.033, = 3.92 × 10; PRS: Nagelkerke's pseudo-R 0.013, = 3.73 × 10). There was strong evidence of interaction between polygenic risk for MS and childhood obesity (PRS: AP = 0.17, 95% CI 0.06-0.25, = 0.004; PRS: AP = 0.17, 95% CI 0.06-0.27, = 0.006).

Conclusions: This study provides novel evidence for an interaction between childhood obesity and a high burden of autosomal genetic risk. These findings may have significant implications for our understanding of MS biology and inform targeted prevention strategies.

Citing Articles

Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy.

Yalcinkaya A, Yalcinkaya R, Sardh F, Landegren N Front Immunol. 2025; 15:1501364.

PMID: 39885993 PMC: 11779622. DOI: 10.3389/fimmu.2024.1501364.


Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study.

Kasbi N, Ezabadi S, Kohandel K, Khodaie F, Sahraian A, Nikkhah Bahrami S BMC Neurol. 2024; 24(1):327.

PMID: 39243006 PMC: 11378646. DOI: 10.1186/s12883-024-03815-9.


Joint modeling of gene-environment correlations and interactions using polygenic risk scores in case-control studies.

Wang Z, Shi W, Carroll R, Chatterjee N Am J Epidemiol. 2024; 193(10):1451-1459.

PMID: 38806447 PMC: 11458198. DOI: 10.1093/aje/kwae081.


Applying a genetic risk score model to enhance prediction of future multiple sclerosis diagnosis at first presentation with optic neuritis.

Loginovic P, Wang F, Li J, Ferrat L, Mirshahi U, Rao H Nat Commun. 2024; 15(1):1415.

PMID: 38418465 PMC: 10902342. DOI: 10.1038/s41467-024-44917-9.


Plasma proteomic profiles of UK Biobank participants with multiple sclerosis.

Jacobs B, Vickaryous N, Giovannoni G, Proitsi P, Waters S, Dobson R Ann Clin Transl Neurol. 2024; 11(3):698-709.

PMID: 38282238 PMC: 10963287. DOI: 10.1002/acn3.51990.


References
1.
Dobson R, Ramagopalan S, Topping J, Smith P, Solanky B, Schmierer K . A Risk Score for Predicting Multiple Sclerosis. PLoS One. 2016; 11(11):e0164992. PMC: 5089761. DOI: 10.1371/journal.pone.0164992. View

2.
He J, Cai Z, Fan X . Accuracy of using self-reported data to screen children and adolescents for overweight and obesity status: A diagnostic meta-analysis. Obes Res Clin Pract. 2017; 11(3):257-267. DOI: 10.1016/j.orcp.2017.03.004. View

3.
Simmonds M, Llewellyn A, Owen C, Woolacott N . Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev. 2015; 17(2):95-107. DOI: 10.1111/obr.12334. View

4.
Bove R, Chua A, Xia Z, Chibnik L, De Jager P, Chitnis T . Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset. Neurol Genet. 2016; 2(4):e88. PMC: 4962522. DOI: 10.1212/NXG.0000000000000088. View

5.
Jacobs B, Noyce A, Giovannoni G, Dobson R . BMI and low vitamin D are causal factors for multiple sclerosis: A Mendelian Randomization study. Neurol Neuroimmunol Neuroinflamm. 2020; 7(2). PMC: 6975169. DOI: 10.1212/NXI.0000000000000662. View